Lánczky A - Search Results

1

Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.

Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Nagy Á, et al. Among authors: lanczky a. Sci Rep. 2018 Jul 26;8(1):11515. doi: 10.1038/s41598-018-29514-3. Sci Rep. 2018. PMID: 30046141 Free PMC article.

2

Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.

Nagy Á, Lánczky A, Menyhárt O, Győrffy B. Nagy Á, et al. Among authors: lanczky a. Sci Rep. 2018 Jun 15;8(1):9227. doi: 10.1038/s41598-018-27521-y. Sci Rep. 2018. PMID: 29907753 Free PMC article. Review.

3

Survival analysis in breast cancer using proteomic data from four independent datasets.

Ősz Á, Lánczky A, Győrffy B. Ősz Á, et al. Among authors: lanczky a. Sci Rep. 2021 Aug 18;11(1):16787. doi: 10.1038/s41598-021-96340-5. Sci Rep. 2021. PMID: 34408238 Free PMC article.

4

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

Gyorffy B, Lánczky A, Szállási Z. Gyorffy B, et al. Among authors: lanczky a. Endocr Relat Cancer. 2012 Apr 10;19(2):197-208. doi: 10.1530/ERC-11-0329. Print 2012 Apr. Endocr Relat Cancer. 2012. PMID: 22277193 Free article.

5

Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.

Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A, Győrffy B. Szász AM, et al. Among authors: lanczky a. Oncotarget. 2016 Aug 2;7(31):49322-49333. doi: 10.18632/oncotarget.10337. Oncotarget. 2016. PMID: 27384994 Free PMC article.

6

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.

Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B. Lánczky A, et al. Breast Cancer Res Treat. 2016 Dec;160(3):439-446. doi: 10.1007/s10549-016-4013-7. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744485

7

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.

Lánczky A, Győrffy B. Lánczky A, et al. J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633. J Med Internet Res. 2021. PMID: 34309564 Free PMC article.

8

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.

Pénzváltó Z, Lánczky A, Lénárt J, Meggyesházi N, Krenács T, Szoboszlai N, Denkert C, Pete I, Győrffy B. Pénzváltó Z, et al. Among authors: lanczky a. BMC Cancer. 2014 Nov 18;14:837. doi: 10.1186/1471-2407-14-837. BMC Cancer. 2014. PMID: 25408231 Free PMC article.

9

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.

Mihály Z, Kormos M, Lánczky A, Dank M, Budczies J, Szász MA, Győrffy B. Mihály Z, et al. Among authors: lanczky a. Breast Cancer Res Treat. 2013 Jul;140(2):219-32. doi: 10.1007/s10549-013-2622-y. Epub 2013 Jul 9. Breast Cancer Res Treat. 2013. PMID: 23836010

10

Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.

Hitti E, Bakheet T, Al-Souhibani N, Moghrabi W, Al-Yahya S, Al-Ghamdi M, Al-Saif M, Shoukri MM, Lánczky A, Grépin R, Győrffy B, Pagès G, Khabar KS. Hitti E, et al. Among authors: lanczky a. Cancer Res. 2016 Jul 15;76(14):4068-80. doi: 10.1158/0008-5472.CAN-15-3110. Epub 2016 May 17. Cancer Res. 2016. PMID: 27197193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters